Follow-The-Filings

NRXP NRX Pharmaceuticals

NRX Pharmaceuticals earnings company data as of 7:18 PM ET 8/21

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period · newest first · EPS & Rev stacked · nothing reported yet

Period Date Metric Estimate Actual Result
FY2026 Q2 14 Aug EPS
Rev

SEC filings

Recent issuer filings from EDGAR · 25 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01
10-Q FORM 10-Q
8-K 7.01
8-K 8.01
8-K 1.01,8.01,9.01
424B5 FORM 424B5
424B5 FORM 424B5
8-K 8.01,9.01
10-Q FORM 10-Q
8-K 5.02,5.07,9.01
10-K FORM 10-K
DEFA14A FORM DEFA14A
424B5 FORM 424B5
8-K 8.01,9.01
8-K 8.01,9.01
8-K 5.02
8-K 3.01,7.01,8.01,9.01
8-K 7.01,9.01
424B3 FORM 424B3
8-K 4.01,9.01
8-K/A 9.01
10-Q FORM 10-Q
8-K 7.01,8.01,9.01
8-K 8.01,9.01
8-K 2.01,7.01,9.01

Insider forms

Form 3 / 4 / 5 from EDGAR · 2 rows shown

Filed Form Detail Links
4 Period Jan 27, 2026
4 Period Apr 9, 2025 · 4 forms

Consensus estimates · SEC filings remain the official record · not investment advice